Short Information | Hemispherx BioPharma Inc. (NYSE:HEB)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 188,465 |
Total Actual Volume | 2,232,233 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 0 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 9,423 |
Average Short Percentage | 8.39% |
Is there a HEB Short Squeeze or Breakout about to happen?
See the HEB Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
08-30-2019 | $1.97 | $1.80 | $1.97 | $1.78 | 14,684 | 185 | 1.26% |
08-29-2019 | $1.938 | $1.81 | $1.938 | $1.78 | 31,067 | 1,512 | 4.87% |
08-28-2019 | $1.893 | $1.86 | $1.9002 | $1.81 | 11,903 | 47 | 0.39% |
08-27-2019 | $1.87 | $1.87 | $1.99 | $1.83 | 38,608 | 509 | 1.32% |
08-26-2019 | $1.92 | $1.90 | $2.00 | $1.90 | 20,549 | 2,404 | 11.7% |
08-23-2019 | $1.90 | $1.93 | $2.06 | $1.8965 | 57,868 | 1,802 | 3.11% |
08-22-2019 | $1.92 | $1.9223 | $1.9599 | $1.8301 | 32,984 | 2,445 | 7.41% |
08-21-2019 | $1.92 | $1.9196 | $1.98 | $1.79 | 35,505 | 2,693 | 7.58% |
08-20-2019 | $1.94 | $1.9201 | $1.9946 | $1.90 | 36,024 | 3,713 | 10.31% |
08-19-2019 | $1.88 | $1.93 | $2.07 | $1.7906 | 70,320 | 5,274 | 7.5% |
08-16-2019 | $2.00 | $1.89 | $2.00 | $1.705 | 89,596 | 10,483 | 11.7% |
08-15-2019 | $2.00 | $1.90 | $2.07 | $1.82 | 58,505 | 3,156 | 5.39% |
08-14-2019 | $2.00 | $1.85 | $2.00 | $1.80 | 59,333 | 802 | 1.35% |
08-13-2019 | $1.84 | $1.89 | $1.959 | $1.81 | 47,364 | 3,899 | 8.23% |
08-12-2019 | $2.02 | $1.86 | $2.02 | $1.69 | 70,256 | 2,452 | 3.49% |
08-09-2019 | $2.19 | $1.99 | $2.19 | $1.91 | 176,184 | 14,415 | 8.18% |
08-08-2019 | $2.37 | $2.22 | $2.44 | $2.10 | 1,238,854 | 100,531 | 8.11% |
08-07-2019 | $2.06 | $2.07 | $2.11 | $2.05 | 47,079 | 19,183 | 40.75% |
08-06-2019 | $2.15 | $2.05 | $2.15 | $2.00 | 37,626 | 3,078 | 8.18% |
08-05-2019 | $2.20 | $2.09 | $2.2365 | $2.02 | 57,924 | 9,882 | 17.06% |
News, Short Squeeze, Breakout and More Instantly...
Hemispherx BioPharma Inc. Company Name:
HEB Stock Symbol:
NYSE Market:
Hemispherx BioPharma Inc. Website:
OCALA, Fla., Aug. 23, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB), an immuno-tech company focused on the research and development of immunological agents to treat multiple types of cancers and immune-deficiency diseases, such as myalgic encephalomyelitis/chronic...
OCALA, Fla., Aug. 15, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency diseases, announces the filing of its report 10Q for the ...
OCALA, Fla., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE American: HEB ) announced today that the University of Pittsburgh Medical Center (UPMC) has issued a final report supporting the safety of using Ampligen in combination therapy for the treatment of recurrent ovar...